Trial intelligence / Profile preview

[18F]SF-DEVD-2 PET Imaging for Tumor Efficacy Monitoring

NCT05828238Phase 1Unknown

Sponsor
Affiliated Hospital of Jiangnan University
Start
Jan 2023
Primary completion
Jan 2024
Countries
1
01

Overview

Phase 1, open-label, single-arm trial, sponsored by Affiliated Hospital of Jiangnan University. Primary endpoint: Evaluation of tissue distribution of [18F]-DEVD-2 at 7 days. Status: unknown.

Beyond the preview

Go deeper on NCT05828238.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05828238.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call